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Background: Primary care providers need an inexpensive, simple, user-friendly, easily 
standardized, sensitive to change, and widely available multidomain instrument to measure the 
cognitive, functional, and psychological symptoms of patients suffering from multiple chronic 
conditions. We previously validated the Caregiver Report Version of the Healthy Aging Brain 
Care Monitor (HABC Monitor) for measuring and monitoring the severity of symptoms through 
caregiver reports. The purpose of this study was to assess the reliability and validity of the Patient 
Self-Report Version of the HABC Monitor (Self-Report HABC Monitor).
Design: Cross-sectional study.
Setting: Primary care clinics affiliated with a safety net urban health care system in Indianapolis, 
Indiana, USA.
Subjects: A total of 291 subjects aged 65 years with a mean age of 72.7 (standard deviation 
6.2) years, 76% female, and 56% African Americans.
Analysis: Psychometric validity and reliability of the Self-Report HABC Monitor.
Results: Among 291 patients analyzed, the Self-Report HABC Monitor demonstrated excellent 
fit for the confirmatory factor analysis model (root mean square error of approximation =0.030, 
comparative fit index =0.974, weighted root mean square residual =0.837) and good internal 
consistency (0.78–0.92). Adequate convergent–divergent validity (differences between the 
Telephone Interview for Cognitive Status test-based cognitive function impairment versus 
nonimpairment groups) was demonstrated only when patients were removed from analysis if 
they had both cognitive function test impairment and suspiciously perfect self-report HABC 
Monitor cognitive floor scores of 0.
Conclusion: The Self-Report HABC Monitor demonstrates good reliability and validity as a 
clinically practical multidimensional tool for measuring symptoms. The tool can be used along 
with its caregiver version to provide useful feedback (via monitoring of symptoms) for modifying 
care plans. Determining the validity of HABC Monitor scores from patients who self-report a 
perfect cognitive score of 0 requires cognitive function test results (eg, Telephone Interview 
for Cognitive Status or Mini Mental State Examination) or Caregiver Report HABC Monitor 
scores or further clinical examination to rule out the possibility that the patient is denying or 
unaware of their cognitive symptoms.
Keywords: symptoms, monitor, validation, cognitive, psychological, functional
Introduction
Older adults attending primary care clinics have multiple chronic conditions that result 
in a spectrum of cognitive, functional, and psychological symptoms.1–3 These  symptoms 
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often reduce the quality of life and lead to high health care 
utilization.1–3 The current primary care system is not designed 
to manage the burden of the cognitive, functional, and psycho-
logical symptoms of multiple chronic conditions.1,4 However, 
randomized controlled trials completed in the last decade5–7 
established the effectiveness of the collaborative care model 
in reducing the burden of cognitive, functional, and psycho-
logical symptoms in primary care. An essential component of 
this collaborative care model was the continuous monitoring 
of both the symptoms and the effectiveness of the individual-
ized care protocols designed to manage these symptoms.4–6,8 
In order to implement this model effectively, primary care 
providers needed a new clinical tool (similar to the blood 
pressure cuff used for the recognition and management of 
hypertension) – a practical, accurate, sensitive-to-change, 
multidomain instrument for measuring and tracking cogni-
tive, functional, and psychological symptoms of patients with 
comorbid chronic conditions.
The Healthy Aging Brain Care (HABC) Monitor was 
developed in 2008 to address the need for such a tool.9 Two ver-
sions of the HABC Monitor were developed in parallel. The 
Caregiver Report Version relies on the observations and 
perceptions of the patient’s informal caregiver, while the 
Self-Report Version is utilized to collect information directly 
from the patient. Both versions of the tool include 27 items to 
measure three domains of the patient’s symptoms (cognitive, 
functional, and psychological). The Caregiver Report Version 
of the HABC Monitor is a reliable, valid, clinically practi-
cal, multidimensional tool for measuring and monitoring the 
symptom severity of patients through their caregiver reports.9 
The objective of the present study is to assess the reliability 
and validity of the Self-Report Version utilizing a cohort of 
patients different from the prior validation study.
Methods
Instrument development
The development of the HABC Monitor was described in 
our earlier paper.9 Briefly, the instrument was developed 
by an interdisciplinary expert panel and was developed 
with a flexible template capable of accommodating paper, 
telephone, or web-based data entry. The developers intended 
the relative benefit of the domains to depend on the clinical 
objective. For example, the cognitive domain (especially 
from the Caregiver Report Version) should be most sensitive 
to facilitating diagnosis of mild cognitive impairment or 
dementia, and the psychological domain should be most 
responsive to therapy.9
Clinical setting and population
The present study uses data from a cross-sectional phone 
survey collected on two cohorts of primary care patients in 
Eskenazi Health, Indianapolis, IN, USA.8 Eskenazi Health 
is a safety net health care system primarily serving an urban 
racially and ethnically mixed population of vulnerable 
adults.4 Patients meeting the following criteria were eligible 
for the study: 1) age 65 years, 2) had at least one visit to 
primary care during the period from January 1, 2008 to 
April 1, 2011, and 3) had any International Classification of 
Diseases, Ninth Revision (ICD-9) code (using both inpatient 
and outpatient Regenstrief Medical Record Systems10 over 
the 3 years 2005–2008) indicating cognitive impairment or 
had received at least one prescription of a cholinesterase 
inhibitor or memantine or had any ICD-9 code indicating 
depression or had received at least one prescription of a 
selective serotonin reuptake inhibitor.
subject recruitment and testing
During a quality improvement project to evaluate the 
implementation of the collaborative care model for patients 
suffering from cognitive or emotional problems, we 
contacted a random sample of patients meeting the inclusion 
criteria at two time points – prior to the implementation of 
the collaborative care model (2009) and 1 year after the 
implementation of such a model (2010). All of the primary 
care providers agreed to allow their patients to be contacted. 
Each patient was asked to complete the Self-Report Version 
of the HABC Monitor and the Telephone Interview for 
Cognitive Status (TICS) over the telephone. All procedures 
were approved by the institutional review board of the Indiana 
University-Purdue University campus in Indianapolis, 
IN, USA.
Assessment questionnaires
Demographic data regarding patients’ age, sex, and race were 
collected during the telephone survey.
hABC Monitor – self-report Version
The Self-Report Version includes 27 items covering 
cognitive, functional, and psychological symptoms. Each 
item has the same item response options consisting of four 
categories capturing the frequency of the target symptoms 
in that past 2 weeks. Table 1 displays all items of the Self-
Report Version instrument. A public website also hosts 
our instrument (http://www.agingbraincare.org/tools/habc-
monitor/).
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TICs
The 11-item TICS was administered to patients over the 
telephone. The TICS is a brief, standardized test of global 
cognitive function developed for use when in-person cog-
nitive testing is impractical or inefficient.11 The tool was 
intended to measure the cognitive functions affected by 
dementia and delirium.12 The TICS items briefly assess ori-
entation, concentration, memory, naming, comprehension, 
calculation, reasoning, judgment, and distal limb praxis.11,12 
The total test score ranges from 0 to 41. A lower score 
represents greater cognitive impairment.
Scaling procedure
Each Self-Report Version scale score was computed by 
summing all items in the scale. Total score was a sum of all 
27 items in the three symptom domains. Higher scores rep-
resent worse scores for individual symptom domains and for 
the overall scale. A person-specific and scale-specific mean of 
nonmissing items was substituted for missing items if 50% 
of the items on the particular scale were missing.
Statistical analysis
The data available for the present study allowed us to assess 
three pieces of validity and reliability evidence – confirmatory 
factor analysis (CFA) of the hypothesized three-factor model 
of patient symptoms, internal consistency, and convergent–
divergent validity.
Data quality and descriptive analyses
Missing data rates were calculated for each item to ensure 
data completeness. Item variability was assessed by 
calculating the item frequency distributions, range, and 
standard deviations. Item and scale scores were examined 
for floor and ceiling effects (ie, clustering of participants at 
the best and worst possible perceptions, respectively).
Psychometric analyses
CFA was performed using Mplus software Version 5.21 
(Muthén and Muthén, Los Angeles, CA, USA).13 All other 
analyses were performed with SAS Version 9.3 (SAS 
Institute Inc., Cary, NC, USA). The following criteria of good 
model fit were used: comparative fit index (CFI) 0.95,14 
root mean square error of approximation (RMSEA) 0.06,14 
and weighted root mean square residual (WRMR) 1.00.15 
To determine whether fit of the confirmatory model could 
be improved by adding paths or cross-loadings, modification 
indices were inspected. The ordinal categorical items were 
modeled with nonlinear ordered logit link functions. Internal 
consistency reliability was estimated with coefficient alpha,16 
with reliability of 0.70 considered as satisfactory for group 
comparison purposes.17 Convergent–divergent validity was 
assessed using analysis of variance and logistic regression-
based receiver operator curve analysis to compare HABC 
Monitor scores between impaired and nonimpaired patient 
groups defined by the TICS cognitive function test scores.
Results
Demographics
Among 985 patients who met the eligibility criteria, 374 were 
unable to be contacted (mostly nonworking phone numbers, 
no answers, and a few patient deaths). Of 611 patients who 
were contacted, 291 agreed to participate in the study and 
completed the telephone survey. Compared with patients who 
could not be contacted (n=374), patients who participated in 
the survey (n=291) did not differ statistically in race (P=0.39) 
or age (P=0.11); participants were more likely (P=0.001) 
to be female (76% vs 64%). Compared with patients who 
refused (n=320), participants (n=291) did not differ statisti-
cally in race (P=0.71); however, participants were more likely 
to be female (76% vs 66%; P=0.002) and were statistically 
younger by a clinically small average difference of 1.1 year 
(mean 72.7 vs 73.8 years; P=0.03).
The mean age of patients who completed the survey was 
72.7 (standard deviation 6.2) years. Females were in the 
majority, constituting 76% of the cohort. There were 162 
(55.7%) African Americans, 116 (39.9%) Caucasians, and 
13 (4.4%) patients who reported other races.
Data quality
All items reported by patients on the Self-Report Version 
exhibited the full range of response categories across the four 
item response options, as demonstrated in Table 1. The item 
responses were more heavily distributed among the 0 and 
1 scores than the 2 and 3 scores. Missing item rates were very 
low and ranged from 0% to 3.8% (Table 1). Item responses 
exhibited enough variability to result in adequate scale score 
variability (eg, range), adequate reliability (as measured by 
Cronbach alpha), and excellent confirmatory dimensionality 
fit, as described next.
CFA
We performed a confirmatory test of the factor analytic 
model. Our hypotheses were that the items would load 
significantly and 0.40 on the prespecified factors and 
would demonstrate acceptable item–total correlations above 
a 0.30 threshold. The hypothesized CFA model was the final 
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model determined from our previous caregiver-reported 
data set.9 We also hypothesized that the factors would 
be significantly correlated. The three-factor CFA model 
demonstrated excellent fit in the present self-reported data: 
RMSEA (0.030), CFI (0.974), and WRMR (0.837) (Table 2). 
All loadings for items on their designated factor were well 
above 0.40, ranging from 0.57 to 0.88 (Table 1). The three 
factors were significantly and substantially correlated (cog-
nitive, functional, r=0.81; cognitive, psychological, r=0.87; 
functional, psychological, r=0.93).
All items were retained based on clinical relevance in 
addition to psychometrics. For example, the “falling or 
tripping” item had the highest item floor effect (92%, ie, 
268/289; Table 1) and the lowest (but acceptable) item–
total correlation (0.32), but this item is very important for 
patient outcomes and had a high factor loading (0.70) on the 
functional subscale, a subscale that had very good internal 
consistency (0.81). Modification indices indicated that the 
model could not be improved by adding paths from items 
to other factors.
We also hypothesized that a single factor model would fit 
the data well because of the comorbidity of symptoms and the 
conceptual and clinical relatedness of the three factors. The 
one-factor CFA model showed adequate fit (as expected, not 
quite as excellent a fit as the three-factor model) with thresh-
olds being satisfied for all three fit indices, indicating that it is 
appropriate to report an HABC Monitor total score in addition 
to three subscale scores. We thank an anonymous reviewer for 
recommending that we compute the average variance extracted 
(AVE) for each of the three latent factors. The AVEs were 
smaller than the squared interfactor correlations (Table 3), sug-
gesting that the three factors are not strongly distinct, which is 
also supported by the good fit of the one-factor model.
We thank the same reviewer for recommending that we 
assess the fit statistics of a post hoc two-factor model in which 
the functional and psychological domains were combined 
(their factor correlation was high, 0.93). We also computed 
fit statistics for the two other post hoc two-factor models. 
Although not quite as good a fit as the three-factor model, all 
two-factor models demonstrated good fit (Table 2). Because 
the three factors have somewhat distinct clinical relevance 
and actionability, and all loadings from the three-factor model 
were 0.40 on their assigned factors, the remaining psycho-
metrics below were investigated for the three subscales in 
addition to the total score. Subscales were scored by sum-
ming the items according to the domain assignments in the 
hypothesized three-factor CFA model in Table 1 because 
modification indices could not improve upon the excellent 
fit of this model. 
reliability and scale score features
We found high internal consistency of the Self-Report Ver-
sion scales (0.78–0.92, Table 3). The observed scale scores 
covered most of the possible score range. In addition, the 
scale scores demonstrated a sufficient dispersion of scores 
for the purpose of assessing and monitoring the symptoms’ 
severity. The largest floor effect (cognitive subscale) did not 
exceed 54%, and the resulting dispersion of subscale and total 
scores was satisfactorily indicated by the wide observed score 
range and the adequate standard deviation for the Self-Report 
Version subscales and total scores (Table 3).
The three patient symptom scales were moderately to 
highly correlated (0.60–0.76), indicating that the domains 
are only somewhat distinct (Table 3). For example, the cor-
relation between functional and psychological scales (0.76) 
implies substantial shared variance between the two scales 
(58%) and yet also substantial variance unique to each scale 
(42%). Because the total score was also highly internally 
consistent, this suggests that the HABC Monitor can be 
reliably scored on both the total score and subscale scores. 
In summary, the Self-Report Version scales demonstrated 
adequate internal consistency and scale score features, includ-
ing ample dispersion of scale scores and moderate to high 
correlations between patient symptom scales.
Convergent–divergent validity
We thank an anonymous reviewer for recommending that we 
investigate the floor effects for the HABC Monitor subscale, 
Table 2 CFA fit statistics 
Fit statistics RMSEA (90% CI) CFI WRMR
Model 1: CFA a priori hypothesized, three factors 0.030 (0.020, 0.039) 0.974 0.837
Model 2: CFA a priori hypothesized, one factor 0.037 (0.028, 0.045) 0.961 0.922
Model 3: Post hoc, two factors, functional/psychological and cognitive 0.032 (0.022, 0.040) 0.971 0.857
Model 4: Post hoc, two factors, cognitive/psychological and functional 0.034 (0.025, 0.042) 0.967 0.888
Model 5: Post hoc, two factors, cognitive/functional and psychological 0.036 (0.027, 0.044) 0.963 0.910
Abbreviations: RMSEA, root mean square error of approximation; CI, confidence interval; CFI, comparative fit index; WRMR, weighted root mean square residual; 
CFA, confirmatory factor analysis.
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which we incorporated into the convergent–divergent valid-
ity analysis. We found that a substantial number of patients 
reported a floor (perfect) score of 0 on the HABC Monitor 
cognitive scale when they also demonstrated impairment on 
the TICS cognitive function test. Self-report validity does 
not require extremely high concordance with cognitive test 
performance because, in isolation, self-reports, performance-
based test results, and the caregiver’s proxy assessments 
likely do not provide a comprehensive picture of the com-
plex symptoms and needs of a person.18,19 Nevertheless, an 
extreme (perfect floor) self-report cognitive scale score of 0 
in the presence of cognitive function test impairment sug-
gests that some patients who are impaired on global cogni-
tive functioning may deny or be unaware of their cognitive 
symptoms when they self-report perfect scores. Therefore, 
we performed the convergent–divergent construct validity 
comparisons both for the total sample and separately after 
removing patients who both reported a floor effect of 0 on the 
HABC Monitor cognitive scale and demonstrated cognitive 
function test impairment on the TICS. Convergent validity is 
supported by the extent to which the HABC Monitor scales 
separate the cognitive function impairment groups defined 
by the TICS test score. The functional and psychological 
scales were expected to differ between TICS groups but not 
by as much as the cognitive scale. Note that because TICS 
is a test of cognitive function, it would be inappropriate to 
remove patients who scored at the floor for the entire HABC 
Monitor total score for this exploratory analysis; instead, we 
removed only patients who scored at the floor for the HABC 
Monitor cognitive score, but only if they also demonstrated 
impairment on the TICS cognitive function test.
We defined impairment on the TICS cognitive function 
test in three different ways to thoroughly explore the floor 
issue in the context of convergent validity. One method 
is based on the TICS manual for defining impairment 
(TICS 0–32).12 The second method employs a cut point com-
monly used by TICS studies20 to define possible clinically 
significant impairment (TICS 0–30). The third method uses 
the crosswalk table in the TICS manual12 to translate TICS 
scores to estimated Mini Mental State Examination (MMSE) 
scores and then to apply a commonly used threshold for 
MMSE scores (MMSE 0–23; TICS 0–26).
In the total sample, none of the HABC Monitor scales 
(cognitive, functional, psychological, total score) sig-
nificantly separated the TICS impaired versus nonimpaired 
groups, regardless of which threshold was used to define 
impairment (Table 4). However, when suspicious self-report 
cognitive score floor effects were removed, the HABC T
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Monitor cognitive scale was significantly different between 
the TICS impairment groups, and the receiver operator 
curve area under the curve (AUC) values were between 0.82 
and 0.85, depending on which TICS threshold was used to 
define cognitive impairment, demonstrating convergent 
validity (Table 4). The functional and psychological HABC 
Monitor scales were also significantly different between 
the TICS impairment groups when suspicious floor effects 
were removed, although, as expected, the AUC values were 
smaller (compared with the AUC for the HABC Monitor 
cognitive scale), ranging from 0.65 to 0.70, demonstrating 
divergent validity. In the total sample, the largest AUC for 
the HABC Monitor cognitive scale was only 0.57, and the 
AUC for the functional and psychological HABC Monitor 
domains was near 0.50 (Table 4). Thus, the Self-Report 
 Version of the HABC Monitor appears to be valid for patients 
who have impairment on cognitive function tests only when 
those patients report HABC Monitor cognitive scores above 
the floor score of 0.
sensitivity analyses
We examined possible effects of race on results. We re-
estimated Cronbach’s coefficient alpha in white versus 
nonwhite patients. Cronbach’s coefficient alpha differed very 
little by race subgroups. Alphas continued to be in the range 
of 0.78–0.92, as they were in the total sample.
Discussion
The Self-Report Version of the HABC Monitor demon-
strates good reliability and validity as a clinically practi-
cal multidimensional tool for assessing and monitoring 
symptoms of older adults attending primary care clinics. 
The self-report tool performed similarly to the caregiver 
report tool with respect to CFA and internal consistency.9 
From a parsimony perspective, the total score is appealing 
because the one-factor model fit the data well, the latent 
factors were not greatly distinct, and patients with multiple 
chronic conditions have symptoms that cluster together, for 
which treating one symptom or disorder often affects other 
symptoms or disorders. However, clinicians may also be 
interested in monitoring the three subscale scores because 
internal psychometric characteristics are only one piece of 
evidence for how to score a tool. One must also consider 
conceptual relevance, clinical actionability, and external 
validity information. For example, greater differences were 
observed between TICS cognitive impairment groups for the 
HABC Monitor cognitive scale than for the HABC Monitor 
functional and psychological scales.
An investigation of self-report cognition floor effects 
and convergent–divergent validity resulted in the following 
caveat regarding cognitive impairment. Both the Self-Report 
HABC Monitor and the Caregiver Report HABC Monitor 
are valid for assessing symptoms of patients who have not 
met thresholds for impairment on cognitive function tests. 
The self-report tool can be used along with the caregiver 
report tool to provide useful feedback (via monitoring of 
symptoms) for modifying care plans. However, for patients 
demonstrating impairment on cognitive function tests, HABC 
Monitor information can be trusted from the Caregiver Report 
Version, but can be trusted from the Self-Report Version 
only for patients who self-report HABC Monitor cognitive 
scores above the perfect floor score of 0. When cognitive 
function test scores (eg, TICS or MMSE) are not available, 
floor scores of 0 on the Self-Report Version of the HABC 
Monitor would require caregiver report information and/or 
further clinical examination to determine whether the patient 
is underreporting their cognitive symptoms. Among patients 
who self-report HABC Monitor cognitive scale scores 0, 
we observed moderate discrimination (according to the AUC) 
between self-report HABC Monitor scores and cognitive 
function test scores. More research is needed to determine 
whether substantial underreporting, denial, or unawareness 
of cognitive symptoms also occurs for patients who are 
impaired on cognitive function tests and who self-report 
HABC  Monitor cognitive scale scores above but near 0 (ie, 
good but not perfect self-report scores such as 1 or 2).
Before the analyses, we had suspected that patient-reported 
items may not “hang together” (ie, internal consistency and 
factor analytic model fit) or exhibit as much variability 
compared with the caregiver-reported data. Indeed, item 
responses were slightly less variable, and item and scale floor 
effects were slightly greater for the self-report data compared 
with the caregiver data, even though the cognitive severity 
of the patient populations was similar in the two studies.9 
However, the internal psychometric properties of the Self-
Report Version were very good, including data quality such 
as item and scale score dispersion, reliability, and CFA model 
fit. For example, coefficient alpha was slightly higher for the 
caregiver-reported scales,9 but the patient-reported scales 
also demonstrated very good internal consistency, with the 
lowest alpha being 0.78. Both patient and caregiver reports 
demonstrated alpha of 0.92 for the total scale.9 Furthermore, 
the hypothesized CFA model showed even better fit in 
patient-reported data than the following good fit shown for 
the caregiver-reported data:9 RMSEA =0.059, CFI =0.929, 
and WRMR =1.055. 
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Limitations
We did not have longitudinal data available in this data set 
to estimate test–retest reliability of the Self-Report Version 
over brief periods of time or to test sensitivity to change over 
longer periods of time. The overall adequacy of the tool must 
be evaluated on both caregiver-reported and patient-reported 
psychometrics. For example, because the tool was designed 
primarily to monitor symptoms over time, a very important 
piece of validity evidence is sensitivity to change, especially 
for the psychological domain, which was expected to be 
the most sensitive to change. Our caregiver-reported study 
showed that all subscales, especially the psychological 
domain, were significantly sensitive to change with respect 
to a gold standard for change in neuropsychiatric symptoms 
(ie, the Neuropsychiatric Inventory).9 Therefore, a limitation 
of the present study is the lack of longitudinal data to assess 
sensitivity to change for self-reported responses.
We did not collect construct–convergent external 
validator scales to compare with the functional and psycho-
logical HABC Monitor domains. However, the TICS was a 
construct–convergent scale to compare with the HABC Mon-
itor cognitive domain. Nor did we have clinical diagnoses for 
assessing diagnostic accuracy. For several reasons, we did not 
determine optimal cut points for sensitivity and specificity 
for the HABC Monitor cognitive scale for detecting TICS 
cognitive impairment. First, at least three sensible thresholds 
exist for dichotomizing the TICS total score into impaired 
and nonimpaired groups. Second, the TICS telephone inter-
view provides an estimate of global cognitive function but 
is not intended to diagnose a specific disorder, which would 
require a more comprehensive cognitive assessment.12 Third, 
our results indicated that the Self-Report Version of the 
HABC Monitor appears to be valid only when floor scores 
of 0 have been removed for patients who demonstrate test-
based cognitive impairment (eg, on the TICS or MMSE). 
Although the HABC Monitor was developed primarily for 
tracking symptoms over time, future research could develop 
cut points for optimal sensitivity and specificity compared 
with gold standard clinical diagnoses. This could be done for 
diagnoses of mild cognitive impairment or dementia, as well 
as diagnoses relevant to other domains, such as diagnoses 
of depression or anxiety, which are relevant to the HABC 
Monitor psychological domain.
For the race subgroup sensitivity analysis, sample 
sizes were not large enough to perform factor analysis or 
to compare TICS impaired versus nonimpaired groups. 
As noted in our earlier article on the Caregiver Report 
Version,9 validating the HABC Monitor in other settings is a 
reasonable next step for both the Self-Report and Caregiver 
Report Versions. With regard to other settings, we are in the 
process of using psychometric results from both caregiver-
reported and patient-reported data sets to develop a brief 
(eg, ten items) version for the busy primary care setting. 
In addition, future research should assess the sensitivity to 
change of the Self-Report Version: eg, compared with reli-
able change scores of valid but lengthier instruments such 
as the Neuropsychiatric Inventory.21
Conclusion
The present report, as well as our earlier report, which 
included supporting evidence for sensitivity to change valid-
ity for the caregiver version of the tool,9 suggests that the 
Caregiver Report and Self-Report Versions of the HABC 
Monitor are reliable, valid, and useful tools for monitoring 
the cognitive, functional, and psychological symptoms of 
patients while delivering care to patients and their caregivers 
under the collaborative care model. However, determining 
the validity of HABC Monitor scores from patients who 
self-report a perfect cognitive score of 0 requires cognitive 
function test results (eg, TICS or MMSE) or Caregiver Report 
HABC Monitor scores or further clinical examination to rule 
out the possibility that the patient is denying or unaware of 
their cognitive symptoms.
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